Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Citius Pharmaceuticals Inc
(NQ:
CTXR
)
0.6031
+0.0168 (+2.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Citius Pharmaceuticals Inc
< Previous
1
2
3
4
Next >
CTXR Stock Earnings: Citius Pharma Meets EPS for Q3 2024
August 12, 2024
CTXR stock results show that Citius Pharma met analyst estimates for earnings per share the third quarter of 2024.
Via
InvestorPlace
Penny Stock Citius Pharmaceuticals Secures Its First FDA Approval For Skin Cancer Drug A Year After FDA Rejection
August 08, 2024
Citius Pharmaceuticals receives FDA approval for Lymphir, the first therapy targeting the IL-2 receptor in relapsed or refractory cutaneous T-cell lymphoma. U.S. market launch planned within five...
Via
Benzinga
Exposures
Product Safety
Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology
August 06, 2024
Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology
Via
News Direct
Citius Pharmaceuticals Nears Market Breakthrough With Two Leading Products
July 30, 2024
Citius Pharmaceuticals Nears Market Breakthrough With Two Leading Products
Via
News Direct
This Pharma Company Is Preparing To Launch Its Lead Candidate
July 25, 2024
This Pharma Company Is Preparing To Launch Its Lead Candidate
Via
News Direct
Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)
July 18, 2024
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 18, 2024) - Investorideas.com, a go-to investing platform releases the second...
Via
Newsfile
Exposures
Product Safety
Analysts Hunt for Undervalued Biotech Stocks
July 17, 2024
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 17, 2024) - Investorideas.com, a go-to investing platform releases the first...
Via
Newsfile
Topics
Economy
Initial Public Offering
Exposures
Interest Rates
Securities Market
Citius Pharmaceuticals (CTXR) Eyes Breakthrough with Late-Stage Drug Pipeline Poised for Regulatory Approval
July 17, 2024
Via
AB Newswire
Bloodstream Infections - From Threats to Solutions
July 11, 2024
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the second...
Via
Newsfile
Topics
Death
Exposures
Death
Citius Pharmaceuticals (CTXR) Nears Key FDA Decisions and Launch Plans for 2024
July 11, 2024
Via
AB Newswire
Exposures
Product Safety
Biopharma Stocks Transformative Innovation for the Future of Health
July 11, 2024
Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the first...
Via
Newsfile
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Citius Pharma's 'Antibiotic Lock' Effective In Patients With Catheter-Associated Bloodstream Infections
May 21, 2024
Citius Pharmaceuticals' Phase 3 trial results for Mino-Lok, an antibiotic lock solution for central line-associated infections, show significant improvement in time to catheter failure and overall...
Via
Benzinga
Yogi Tea Recalls: Yogi Brand Recalls 900,000 Tea Bags for Pesticide Residue
May 21, 2024
Yogi Tea recalls are in effect for some of the company's tea bags over concerns of pesticide residue that may be found in them.
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
VFS Stock Alert: VinFast Plunges on NHTSA Probe
May 21, 2024
VinFast Auto stock is down on Tuesday as investors in VFS learn that the company is being investigated over a fatal crash last month.
Via
InvestorPlace
Why Is Citius Pharmaceuticals (CTXR) Stock Up 11% Today?
May 21, 2024
Citius Pharmaceuticals stock is up on Tuesday with heavy trading of CTXR shares alongside positive clinical trial results.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 21, 2024
Via
Benzinga
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) Featured in Coverage of the EF Hutton Annual Global Conference
May 16, 2024
Via
Investor Brand Network
Exposures
Product Safety
CTXR Stock Earnings: Citius Pharma Meets EPS for Q2 2024
May 14, 2024
CTXR stock results show that Citius Pharma met analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment
April 18, 2024
Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment
Via
News Direct
Topics
Death
Exposures
Death
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 18, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 18, 2024
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Thursday morning!
Via
InvestorPlace
Sidoti Events, LLC’s Virtual November Micro-Cap Conference
November 14, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 24, 2023
Via
Benzinga
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
July 31, 2023
Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report.
Via
Benzinga
Why Citius Pharmaceuticals Stock Is Plunging Today?
July 31, 2023
The FDA issued a Complete Response Letter regarding Citius Pharmaceuticals Inc's (NASDAQ: CTXR) Biologics License Application (BLA) seeking approval for denileukin diftitox (Lymphir), an engineered...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 31, 2023
Via
Benzinga
Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
July 31, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
July 31, 2023
It's time to start off the week with a breakdown of the biggest pre-market stock movers worth watching for Monday morning!
Via
InvestorPlace
CSX, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session
July 31, 2023
U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Combination Therapy for Hemorrhoids: Citius' Combination Products Shows Meaningful Reduction In Symptoms
June 20, 2023
Citius Pharmaceuticals Inc's (NASDAQ: CTXR) Halo-Lido, a topical treatment comprising lidocaine and halobetasol for hemorrhoid relief, significantly reduced symptom severity compared to individual
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.